Pharma firm Eugia recalls antibacterial drug in the US over glass particles

Eugia US LLC is voluntarily recalling a lot of Vancomycin Hydrochloride for Injection due to the presence of a glass particle inside the vial.

Details of Recall

The recalled product is Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL in single dose vials. The company shipped this entire lot to wholesalers in the U.S. between September 2 and September 15. Eugia has notified its distributors and customers through recall letters and is currently arranging for the return and replacement of all recalled products, according to the U.S. Food and Drug Administration.

Drug Usage

Vancomycin hydrochloride for injection is a glycopeptide antibacterial medicine. Doctors use it to treat both adult and paediatric patients, including neonates and older children. The drug is indicated for serious conditions like septicaemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.

Context

Eugia US LLC was previously known as Auro Medics Pharma LLC and operates as a subsidiary of Aurobindo Pharma. Pharmaceutical companies issue voluntary recalls when quality checks or post-shipping reports identify foreign matter or manufacturing defects, ensuring safety standards are met before patients receive the medication.